Boston Scientific Corporation (LON:0HOY)
97.39
+0.94 (0.97%)
At close: Oct 9, 2025
Boston Scientific Revenue
Boston Scientific had revenue of $5.06B USD in the quarter ending June 30, 2025, with 22.84% growth. This brings the company's revenue in the last twelve months to $18.49B, up 21.45% year-over-year. In the year 2024, Boston Scientific had annual revenue of $16.75B with 17.61% growth.
Revenue (ttm)
$18.49B
Revenue Growth
+21.45%
P/S Ratio
8.03
Revenue / Employee
$348.94K
Employees
53,000
Market Cap
108.38B GBP
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 16.75B | 2.51B | 17.61% |
Dec 31, 2023 | 14.24B | 1.56B | 12.29% |
Dec 31, 2022 | 12.68B | 794.00M | 6.68% |
Dec 31, 2021 | 11.89B | 1.98B | 19.92% |
Dec 31, 2020 | 9.91B | -822.00M | -7.66% |
Dec 31, 2019 | 10.74B | 912.00M | 9.28% |
Dec 31, 2018 | 9.82B | 775.00M | 8.57% |
Dec 31, 2017 | 9.05B | 662.00M | 7.89% |
Dec 31, 2016 | 8.39B | 909.00M | 12.16% |
Dec 31, 2015 | 7.48B | 97.00M | 1.31% |
Dec 31, 2014 | 7.38B | 237.00M | 3.32% |
Dec 31, 2013 | 7.14B | -106.00M | -1.46% |
Dec 31, 2012 | 7.25B | -373.00M | -4.89% |
Dec 31, 2011 | 7.62B | -184.00M | -2.36% |
Dec 31, 2010 | 7.81B | -382.00M | -4.67% |
Dec 31, 2009 | 8.19B | 138.00M | 1.71% |
Dec 31, 2008 | 8.05B | -307.00M | -3.67% |
Dec 31, 2007 | 8.36B | 536.00M | 6.85% |
Dec 31, 2006 | 7.82B | 1.54B | 24.48% |
Dec 31, 2005 | 6.28B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca | 41.24B |
GSK plc | 31.63B |
Haleon | 11.02B |
Smith & Nephew | 4.33B |
ConvaTec Group | 1.72B |
Hikma Pharmaceuticals | 2.35B |
HUTCHMED (China) | 439.54M |
Genus | 672.80M |
Boston Scientific News
- 1 day ago - November 28th Options Now Available For Boston Scientific (BSX) - Nasdaq
- 1 day ago - 4 Top AI-Powered Healthcare Stocks - Seeking Alpha
- 1 day ago - Boston Scientific: Not In The Most Resolute State As It Approaches Q3 Earnings - Seeking Alpha
- 3 days ago - Evercore ISI Revises Boston Scientific (BSX) Price Target to $110 | BSX Stock News - GuruFocus
- 3 days ago - Boston Scientific (BSX) Target Price Cut by Evercore ISI Amid Market Concerns - GuruFocus
- 7 days ago - The Zacks Analyst Blog Highlights Boston Scientific, Union Pacific, Realty Income and Weyco - Nasdaq
- 8 days ago - Top Research Reports for Boston Scientific, Union Pacific & Realty Income - Nasdaq
- 9 days ago - BSX Factor-Based Stock Analysis - Peter Lynch - Nasdaq